DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20163027

Two interesting cases of gestational trophoblastic disease with methotrexate failure

Poonam Laul, Pinkee Saxena, Vijay K. Kadam, Urvashi Miglani

Abstract


Gestational trophoblastic disease is group tumours that are more sensitive and respond well to a wide variety of chemotherapeutic regimes. Presented here are two interesting cases one with life threatening bleeding requiring hysterectomy and other with persistent disease post evacuation. Both being low risk were treated with single agent methotrexate, but failed to respond. They responded to alternative chemotherapy. Methotrexate resistant is seen even in low risk group.

Keywords


Choriocarcinoma, Uterine perforation, Methotrexate

Full Text:

PDF

References


Dasari P. Missing choriocarcinoma may be easy but not suspecting it in a high-risk case can be potentially fatal. BMJ Case Rep. 2015.

Topuz S, Iyibozkurt C, Mete O, Akhan S, Saliho─člu Y, Bengisu E, Berkman S. Life-saving hysterectomy in choriocarcinoma: presentation of two cases, Eur J Gynaecol Oncol. 2008;29(6):664-5.

Alazzam M, Hancock BW, Tidy J. Role of hysterectomy in managing persistent gestational trophoblastic disease, J Reprod Med. 2008;53(7):519-24.

Chalouhi GE, Golfier F, Soignon P, Massardier J, Guastalla JP, Trillet-Lenoir V. Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity, Am J Obstet Gynecol. 2009;200(6):643.

Matsui H, Suzuka K, Yamazawa K, Tanaka N, Mitsuhashi A, Seki K. Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy. Gynecol Oncol. 2005;96(3):616-20.

Growdon WB, Wolfberg AJ, Goldstein DP, Feltmate CM, Chinchilla ME, Lieberman ES. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy. J Reprod Med. 2010;55(7-8):279-84.

Chen YX, Shen YM, Qian JH, Xie X. Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors there of Zhonghua Yi Xue Za Zhi. 2005;85(30):2109-12.